SELLAS Life Sciences Group, Inc. SLS
14.86 USD -3.09 (-17.21%)
Regular-session close
14.85 -0.01 -0.07%
Pre-market · Nov 20, 5:23 AM ET
14.23 Day range 16.54
1.39 52-week range 24.89
- YTD
- +294.16%
- 1 year
- +917.81%
Revenue & Expenses
Revenue Profit Costs
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 28.27M | 31.51M | 37.87M | 42.85M | 32.69M | |
| 16.02M | 19.10M | 24.01M | 20.27M | 15.67M | |
| 12.25M | 12.42M | 13.86M | 12.58M | 11.32M | |
| -28.27M | -31.51M | -37.87M | -41.95M | -25.29M | |
| -26.86M | -30.88M | -37.34M | -41.30M | -20.70M | |
| -26.86M | -30.88M | -37.34M | -41.30M | -20.70M | |
| -26.86M | -30.88M | -37.34M | -41.30M | -20.70M | |
| -26.86M | -30.88M | -37.34M | -41.30M | -20.70M | |
| -0.25 | -0.50 | -1.34 | -2.13 | -1.34 | |
| -0.25 | -0.50 | -1.34 | -2.13 | -1.34 | |
| -0.25 | -0.50 | -1.34 | -2.13 | -1.34 | |
| -26.86M | -30.88M | -37.34M | -41.30M | -20.94M | |
| -26.86M | -30.88M | -37.34M | -41.30M | -20.94M | |
| 109.05M | 61.20M | 27.78M | 19.40M | 15.48M | |
| 109.05M | 61.20M | 27.78M | 19.40M | 15.48M |
